title: Initial experience with ribavirin plus glycyrrhizin in renal allograft recipients with chronic hepatitis C.
authors.forename: Anil C
authors.initials: AC
authors.lastname: Anand
authors.forename: Avnish K
authors.initials: AK
authors.lastname: Seth
authors.forename: Akhil
authors.initials: A
authors.lastname: Nagpal
authors.forename: Prem P
authors.initials: PP
authors.lastname: Varma
authors.forename: S R
authors.initials: SR
authors.lastname: Gadela
authors.forename: K V
authors.initials: KV
authors.lastname: Baliga
authors.forename: Vibha
authors.initials: V
authors.lastname: Dutta
authors.forename: G S
authors.initials: GS
authors.lastname: Chopra
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D019695:Glycyrrhizic Acid / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000998:Antiviral Agents; D012254:Ribavirin; D019695:Glycyrrhizic Acid